IPC-Stelle: A61P [Version 2017.01]

SymbolTypTitel
ASKHUMAN NECESSITIES
A61USKHEALTH; LIFE-SAVING; AMUSEMENT
A61KLMEDICAL OR VETERINARY SCIENCE; HYGIENE
A61PUKLSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS [7]
A61P 1/00HGRDrugs for disorders of the alimentary tract or the digestive system [7, 2006.01]
A61P 1/02UGR1
.Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis [7, 2006.01]
A61P 1/04UGR1
.for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants [7, 2006.01]
A61P 1/06UGR1
.Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia [7, 2006.01]
A61P 1/08UGR1
.for nausea, cinetosis or vertigo; Antiemetics [7, 2006.01]
A61P 1/10UGR1
.Laxatives [7, 2006.01]
A61P 1/12UGR1
.Antidiarrhoeals [7, 2006.01]
A61P 1/14UGR1
.Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents [7, 2006.01]
A61P 1/16UGR1
.for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics [7, 2006.01]
A61P 1/18UGR1
.for pancreatic disorders, e.g. pancreatic enzymes [7, 2006.01]
A61P 3/00HGRDrugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) [7, 2006.01]
A61P 3/02UGR1
.Nutrients, e.g. vitamins, minerals [7, 2006.01]
A61P 3/04UGR1
.Anorexiants; Antiobesity agents [7, 2006.01]
A61P 3/06UGR1
.Antihyperlipidemics [7, 2006.01]
A61P 3/08UGR1
.for glucose homeostasis (pancreatic hormones A61P 5/48) [7, 2006.01]
A61P 3/10UGR2
. .for hyperglycaemia, e.g. antidiabetics [7, 2006.01]
A61P 3/12UGR1
.for electrolyte homeostasis [7, 2006.01]
A61P 3/14UGR2
. .for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/10; bone metastasis A61P 35/04) [7, 2006.01]
A61P 5/00HGRDrugs for disorders of the endocrine system [7, 2006.01]
A61P 5/02UGR1
.of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin [7, 2006.01]
A61P 5/04UGR2
. .for decreasing, blocking or antagonising the activity of the hypothalamic hormones [7, 2006.01]
A61P 5/06UGR1
.of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH [7, 2006.01]
A61P 5/08UGR2
. .for decreasing, blocking or antagonising the activity of the anterior pituitary hormones [7, 2006.01]
A61P 5/10UGR1
.of the posterior pituitary hormones, e.g. oxytocin, ADH [7, 2006.01]
A61P 5/12UGR2
. .for decreasing, blocking or antagonising the activity of the posterior pituitary hormones [7, 2006.01]
A61P 5/14UGR1
.of the thyroid hormones, e.g. T3, T4 [7, 2006.01]
A61P 5/16UGR2
. .for decreasing, blocking or antagonising the activity of the thyroid hormones [7, 2006.01]
A61P 5/18UGR1
.of the parathyroid hormones [7, 2006.01]
A61P 5/20UGR2
. .for decreasing, blocking or antagonising the activity of PTH [7, 2006.01]
A61P 5/22UGR2
. .for decreasing, blocking or antagonising the activity of calcitonin [7, 2006.01]
A61P 5/24UGR1
.of the sex hormones [7, 2006.01]
A61P 5/26UGR2
. .Androgens [7, 2006.01]
A61P 5/28UGR2
. .Antiandrogens [7, 2006.01]
A61P 5/30UGR2
. .Oestrogens [7, 2006.01]
A61P 5/32UGR2
. .Antioestrogens [7, 2006.01]
A61P 5/34UGR2
. .Gestagens [7, 2006.01]
A61P 5/36UGR2
. .Antigestagens [7, 2006.01]
A61P 5/38UGR1
.of the suprarenal hormones [7, 2006.01]
A61P 5/40UGR2
. .Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids [7, 2006.01]
A61P 5/42UGR2
. .for decreasing, blocking or antagonising the activity of mineralocorticosteroids [7, 2006.01]
A61P 5/44UGR2
. .Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids [7, 2006.01]
A61P 5/46UGR2
. .for decreasing, blocking or antagonising the activity of glucocorticosteroids [7, 2006.01]
A61P 5/48UGR1
.of the pancreatic hormones [7, 2006.01]
A61P 5/50UGR2
. .for increasing or potentiating the activity of insulin [7, 2006.01]
A61P 7/00HGRDrugs for disorders of the blood or the extracellular fluid [7, 2006.01]
A61P 7/02UGR1
.Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors [7, 2006.01]
A61P 7/04UGR1
.Antihaemorrhagics; Procoagulants; Haemostatatic agents; Antifibrinolytic agents [7, 2006.01]
A61P 7/06UGR1
.Antianaemics [7, 2006.01]
A61P 7/08UGR1
.Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P 27/04) [7, 2006.01]
A61P 7/10UGR1
.Antioedematous agents; Diuretics [7, 2006.01]
A61P 7/12UGR1
.Antidiuretics, e.g. drugs for diabetes insipidus (ADH A61P 5/10) [7, 2006.01]
A61P 9/00HGRDrugs for disorders of the cardiovascular system [7, 2006.01]
A61P 9/02UGR1
.Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives [7, 2006.01]
A61P 9/04UGR1
.Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure [7, 2006.01]
A61P 9/06UGR1
.Antiarrhythmics [7, 2006.01]
A61P 9/08UGR1
.Vasodilators for multiple indications [7, 2006.01]
A61P 9/10UGR1
.for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis [7, 2006.01]
A61P 9/12UGR1
.Antihypertensives [7, 2006.01]
A61P 9/14UGR1
.Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers [7, 2006.01]
A61P 11/00HGRDrugs for disorders of the respiratory system [7, 2006.01]
A61P 11/02UGR1
.Nasal agents, e.g. decongestants [7, 2006.01]
A61P 11/04UGR1
.for throat disorders [7, 2006.01]
A61P 11/06UGR1
.Antiasthmatics [7, 2006.01]
A61P 11/08UGR1
.Bronchodilators [7, 2006.01]
A61P 11/10UGR1
.Expectorants [7, 2006.01]
A61P 11/12UGR1
.Mucolytics [7, 2006.01]
A61P 11/14UGR1
.Antitussive agents [7, 2006.01]
A61P 11/16UGR1
.Central respiratory analeptics [7, 2006.01]
A61P 13/00HGRDrugs for disorders of the urinary system (diuretics A61P 7/10) [7, 2006.01]
A61P 13/02UGR1
.of urine or of the urinary tract, e.g. urine acidifiers [7, 2006.01]
A61P 13/04UGR1
.for urolithiasis [7, 2006.01]
A61P 13/06UGR1
.Anti-spasmodics [7, 2006.01]
A61P 13/08UGR1
.of the prostate [7, 2006.01]
A61P 13/10UGR1
.of the bladder [7, 2006.01]
A61P 13/12UGR1
.of the kidneys [7, 2006.01]
A61P 15/00HGRDrugs for genital or sexual disorders (for disorders of sex hormones A61P 5/24); Contraceptives [7, 2006.01]
A61P 15/02UGR1
.for disorders of the vagina [7, 2006.01]
A61P 15/04UGR1
.for inducing labour or abortion; Uterotonics [7, 2006.01]
A61P 15/06UGR1
.Antiabortive agents; Labour repressants [7, 2006.01]
A61P 15/08UGR1
.for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis [7, 2006.01]
A61P 15/10UGR1
.for impotence [7, 2006.01]
A61P 15/12UGR1
.for climacteric disorders [7, 2006.01]
A61P 15/14UGR1
.for lactation disorders, e.g. galactorrhoea [7, 2006.01]
A61P 15/16UGR1
.Masculine contraceptives [7, 2006.01]
A61P 15/18UGR1
.Feminine contraceptives [7, 2006.01]
A61P 17/00HGRDrugs for dermatological disorders [7, 2006.01]
A61P 17/02UGR1
.for treating wounds, ulcers, burns, scars, keloids, or the like [7, 2006.01]
A61P 17/04UGR1
.Antipruritics [7, 2006.01]
A61P 17/06UGR1
.Antipsoriatics [7, 2006.01]
A61P 17/08UGR1
.Antiseborrheics [7, 2006.01]
A61P 17/10UGR1
.Anti-acne agents [7, 2006.01]
A61P 17/12UGR1
.Keratolytics, e.g. wart or anti-corn preparations [7, 2006.01]
A61P 17/14UGR1
.for baldness or alopecia [7, 2006.01]
A61P 17/16UGR1
.Emollients or protectives, e.g. against radiation [7, 2006.01]
A61P 17/18UGR1
.Antioxidants, e.g. antiradicals (preparations for protection against sunlight A61Q 17/00) [2006.01]
A61P 19/00HGRDrugs for skeletal disorders [7, 2006.01]
A61P 19/02UGR1
.for joint disorders, e.g. arthritis, arthrosis [7, 2006.01]
A61P 19/04UGR1
.for non-specific disorders of the connective tissue [7, 2006.01]
A61P 19/06UGR1
.Antigout agents, e.g. antihyperuricemic or uricosuric agents [7, 2006.01]
A61P 19/08UGR1
.for bone diseases, e.g. rachitism, Paget's disease [7, 2006.01]
A61P 19/10UGR2
. .for osteoporosis [7, 2006.01]
A61P 21/00HGRDrugs for disorders of the muscular or neuromuscular system [7, 2006.01]
A61P 21/02UGR1
.Muscle relaxants, e.g. for tetanus or cramps [7, 2006.01]
A61P 21/04UGR1
.for myasthenia gravis [7, 2006.01]
A61P 21/06UGR1
.Anabolic agents (androgens A61P 5/26) [7, 2006.01]
A61P 23/00HGRAnaesthetics [7, 2006.01]
A61P 23/02UGR1
.Local anaesthetics [7, 2006.01]
A61P 25/00HGRDrugs for disorders of the nervous system [7, 2006.01]
A61P 25/02UGR1
.for peripheral neuropathies [7, 2006.01]
A61P 25/04UGR1
.Centrally acting analgesics, e.g. opioids [7, 2006.01]
A61P 25/06UGR1
.Antimigraine agents [7, 2006.01]
A61P 25/08UGR1
.Antiepileptics; Anticonvulsants [7, 2006.01]
A61P 25/10UGR2
. .for petit-mal [7, 2006.01]
A61P 25/12UGR2
. .for grand-mal [7, 2006.01]
A61P 25/14UGR1
.for treating abnormal movements, e.g. chorea, dyskinesia [7, 2006.01]
A61P 25/16UGR2
. .Anti-Parkinson drugs [7, 2006.01]
A61P 25/18UGR1
.Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia [7, 2006.01]
A61P 25/20UGR1
.Hypnotics; Sedatives [7, 2006.01]
A61P 25/22UGR1
.Anxiolytics [7, 2006.01]
A61P 25/24UGR1
.Antidepressants [7, 2006.01]
A61P 25/26UGR1
.Psychostimulants, e.g. nicotine, cocaine [7, 2006.01]
A61P 25/28UGR1
.for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia [7, 2006.01]
A61P 25/30UGR1
.for treating abuse or dependence [7, 2006.01]
A61P 25/32UGR2
. .Alcohol-abuse [7, 2006.01]
A61P 25/34UGR2
. .Tobacco-abuse [7, 2006.01]
A61P 25/36UGR2
. .Opioid-abuse [7, 2006.01]
A61P 27/00HGRDrugs for disorders of the senses [7, 2006.01]
A61P 27/02UGR1
.Ophthalmic agents [7, 2006.01]
A61P 27/04UGR2
. .Artificial tears; Irrigation solutions [7, 2006.01]
A61P 27/06UGR2
. .Antiglaucoma agents or miotics [7, 2006.01]
A61P 27/08UGR2
. .Mydriatics or cycloplegics [7, 2006.01]
A61P 27/10UGR2
. .for accommodation disorders, e.g. myopia [7, 2006.01]
A61P 27/12UGR2
. .for cataracts [7, 2006.01]
A61P 27/14UGR2
. .Decongestants or antiallergics [7, 2006.01]
A61P 27/16UGR1
.Otologicals [7, 2006.01]
A61P 29/00HGRNon-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (NSAIDs) [7, 2006.01]
A61P 29/02UGR1
.without antiinflammatory effect [7, 2006.01]
A61P 31/00HGRAntiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics [7, 2006.01]
A61P 31/02UGR1
.Local antiseptics [7, 2006.01]
A61P 31/04UGR1
.Antibacterial agents [7, 2006.01]
A61P 31/06UGR2
. .for tuberculosis [7, 2006.01]
A61P 31/08UGR2
. .for leprosy [7, 2006.01]
A61P 31/10UGR1
.Antimycotics [7, 2006.01]
A61P 31/12UGR1
.Antivirals [7, 2006.01]
A61P 31/14UGR2
. .for RNA viruses [7, 2006.01]
A61P 31/16UGR3
. . .for influenza or rhinoviruses [7, 2006.01]
A61P 31/18UGR3
. . .for HIV [7, 2006.01]
A61P 31/20UGR2
. .for DNA viruses [7, 2006.01]
A61P 31/22UGR3
. . .for herpes viruses [7, 2006.01]
A61P 33/00HGRAntiparasitic agents [7, 2006.01]
A61P 33/02UGR1
.Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis [7, 2006.01]
A61P 33/04UGR2
. .Amoebicides [7, 2006.01]
A61P 33/06UGR2
. .Antimalarials [7, 2006.01]
A61P 33/08UGR2
. .for Pneumocystis carinii [7, 2006.01]
A61P 33/10UGR1
.Anthelmintics [7, 2006.01]
A61P 33/12UGR2
. .Schistosomicides [7, 2006.01]
A61P 33/14UGR1
.Ectoparasiticides, e.g. scabicides [7, 2006.01]
A61P 35/00HGRAntineoplastic agents [7, 2006.01]
A61P 35/02UGR1
.specific for leukemia [7, 2006.01]
A61P 35/04UGR1
.specific for metastasis [7, 2006.01]
A61P 37/00HGRDrugs for immunological or allergic disorders [7, 2006.01]
A61P 37/02UGR1
.Immunomodulators [7, 2006.01]
A61P 37/04UGR2
. .Immunostimulants [7, 2006.01]
A61P 37/06UGR2
. .Immunosuppressants, e.g. drugs for graft rejection [7, 2006.01]
A61P 37/08UGR1
.Antiallergic agents (antiasthmatic agents A61P 11/06; ophthalmic antiallergics A61P 27/14) [7, 2006.01]
A61P 39/00HGRGeneral protective or antinoxious agents [7, 2006.01]
A61P 39/02UGR1
.Antidotes [7, 2006.01]
A61P 39/04UGR1
.Chelating agents [7, 2006.01]
A61P 39/06UGR1
.Free radical scavengers or antioxidants [7, 2006.01]
A61P 41/00HGRDrugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution [7, 2006.01]
A61P 43/00HGRDrugs for specific purposes, not provided for in groups A61P 1/00-A61P 41/00 [7, 2006.01]